The golden hour in shock management: do a lot, do it quickly.

Autor: Marini M; University Hospital of Marche., Belleggia S; University Hospital of Marche., Brugiatelli L; University Hospital of Marche., Francioni M; University Hospital of Marche., Battistoni I; University Hospital of Marche., Shkoza M; University Hospital of Marche., Pongetti G; University Hospital of Marche., Angelini L; University Hospital of Marche., Belfioretti L; University Hospital of Marche., Matassini MV; University Hospital of Marche.
Jazyk: angličtina
Zdroj: European heart journal supplements : journal of the European Society of Cardiology [Eur Heart J Suppl] 2024 Apr 17; Vol. 26 (Suppl 1), pp. i78-i83. Date of Electronic Publication: 2024 Apr 17 (Print Publication: 2024).
DOI: 10.1093/eurheartjsupp/suae023
Abstrakt: Cardiogenic shock can be defined as a state of inadequate organ perfusion linked primarily to cardiac pump dysfunction. The two predominant causes of this condition are acute myocardial infarction and acutely decompensated heart failure (ADHF). In recent years, a significant increase in cases of cardiogenic shock from ADHF has been described. Recent evidence has defined that the factors with the greatest impact on the prognosis in this context are the early clinical assessment, the definition of the aetiology, the timely application of pharmacological therapies, or individualized mechanical supports for the circulation. Haemodynamic monitoring can help in the phenotyping of cardiogenic shock and therefore guide therapeutic choices, especially if implemented with the aid of advanced monitoring tools such as the Swan-Ganz catheter. Finally, the presence of a dedicated shock team in the 'hub' centres is fundamental, which facilitates the choice of the best therapeutic strategy on a case-by-case basis.
Competing Interests: Conflict of interest: none declared.
(© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.)
Databáze: MEDLINE
Externí odkaz: